InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (2 ops.)
Browse the detailed record of transactions filed by Niklason Laura E, Chairman & CEO. Insider active across 1 companies, notably Humacyte, Inc.. In total, 5 disclosures have been logged. Total volume traded: €457k. The latest transaction was disclosed on 23 May 2022 — Acquisition. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations5 total
€45,21610,000 shares@ €4.52169.9% of flow
Common Stock
SEC:0001818382-22-000050:0·
Ideal exit: 17 Feb 2023 (T+270)
€205,71123,694 shares@ €8.682100.0% of flow
Common Stock
SEC:0001104659-21-150678·
€205,71123,694 shares@ €8.68245.0% of flow
Common Stock
SEC:0001104659-21-150678:0·
1,148,240 shares
Common Stock
SEC:0001104659-21-110547·
1,148,240 shares
Common Stock
SEC:0001104659-21-110547:0·
5 of 5 declarations
About Niklason Laura E
Laura E. Niklason is the President, CEO and Director at Humacyte, Inc. She leads the company with a focus on innovation in the field of cell therapies. Her leadership is essential for the development and implementation of new medical solutions.
